Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Open-Label, Multicentre Study to Assess the Pharmacokinetics and Safety of Naloxegol in Paediatric Patients Ages ≥ 6 Months to < 18 Years Receiving Treatment With Opioids

NCT02099591 is registered in ClinicalTrials.gov with Kyowa Kirin Pharmaceutical Development Ltd as lead sponsor.

NCT NCT02099591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02099591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Open-Label, Multicentre Study to Assess the Pharmacokinetics and Safety of Naloxegol in Paediatric Patients Ages ≥ 6 Months to < 18 Years Receiving Treatment With Opioids
Lead sponsor
Kyowa Kirin Pharmaceutical Development Ltd
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2014
Completion date
April 30, 2021
Enrollment
61 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

constipation, signs and symptoms, digestive